KIMIA BIOSCIENCES
Back to Income Statement
|
KIMIA BIOSCIENCES Last 5 Year Revenue History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹105 Cr | ₹129 Cr | ₹125 Cr | ₹133 Cr | ₹106 Cr |
What is the latest Revenue of KIMIA BIOSCIENCES ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹105 Cr |
| Mar2024 | ₹129 Cr |
| Mar2023 | ₹125 Cr |
| Mar2022 | ₹133 Cr |
| Mar2021 | ₹106 Cr |
How is Revenue of KIMIA BIOSCIENCES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹105 Cr | -18.39 | |
| Mar2024 | ₹129 Cr | 2.89 | |
| Mar2023 | ₹125 Cr | -5.89 | |
| Mar2022 | ₹133 Cr | 24.86 | |
| Mar2021 | ₹106 Cr | - | |
Compare Revenue of peers of KIMIA BIOSCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KIMIA BIOSCIENCES | ₹156.3 Cr | 9.9% | -0.2% | -51.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,870.0 Cr | 0.7% | 8.1% | 16% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,316.0 Cr | 7% | 10.2% | 3.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹169,316.0 Cr | 2.5% | 11.3% | 49.6% | Stock Analytics | |
| CIPLA | ₹115,477.0 Cr | -0.3% | 4.1% | -3.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,156.0 Cr | -3.2% | -3.9% | -3% | Stock Analytics | |
KIMIA BIOSCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KIMIA BIOSCIENCES | 9.9% |
-0.2% |
-51.1% |
| SENSEX | 0.6% |
1.2% |
-7.8% |
You may also like the below Video Courses